CD8A and neoplasm: Although both ROCK inhibitors fasudil and AT13148 had similar anti-tumour effects (Figure 5 and Figure 6), neither treatment increased neutrophil nor CD8+ T cell recruitment to tumours in contrast to the observations in ROCK1nc mice (Figure 3 and Figure 4).